HYFC

Genexine, Inc.

Application Filed: 2014-12-15

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	79164661
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Law Office Assigned	N30
Employee Name	PAINTER, VALERIYA SHER

Timeline

2014-12-15	Application Filed
2015-11-16	Abandon
2015-12-15	Location: TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED
2015-12-15	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Genexine, Inc.
Address	4th fl., Bldg B, Korea Bio Park, 700, Daewangpangyo-ro,Bundang-gu,, Seongnam-si, Gyeonggi-do KR
Legal Entity Type	Corporation
Legal Entity State	KR

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

DARAE IP FIRM
(KIPS, Yeoksam-dong; 10th Floor, 131, Te
Seoul 135-080
REPUBLIC OF KOREA

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceuticals; vaccines; anti-cancer preparations; antibiotics; antibiotic preparations; pills for inflammation treatment; cardiovascular pharmaceutical preparations; medicines for sensory organs; pharmaceutical preparations for digestive organs; dermatological pharmaceutical products; blood solvent; agents affecting metabolism; anti-inflammatory preparations; disinfectants for hygiene purposes; fungicides; medicated candy; agents for treatment of diabetes; asthmatic agents; immunoglobulin fusion protein agents; medicines for the treatment of neutropenia; medicines for the treatment of anemia; medicines for the treatment of dwarfism; medicines for the treatment of inflammatory bowel disease; medicines for the treatment of short-bowel syndrome; medicines for the treatment of psoriasis; medicines for the treatment of proliferative arthritis; medicines for the treatment of systemic lupus erythematosus; medicines for the treatment of cervical tumor

Type Code

Type

GS0051

Pharmaceuticals; vaccines; anti-cancer preparations; antibiotics; antibiotic preparations; pills for inflammation treatment; cardiovascular pharmaceutical preparations; medicines for sensory organs; pharmaceutical preparations for digestive organs; dermatological pharmaceutical products; blood solvent; agents affecting metabolism; anti-inflammatory preparations; disinfectants for hygiene purposes; fungicides; medicated candy; agents for treatment of diabetes; asthmatic agents; immunoglobulin fusion protein agents; medicines for the treatment of neutropenia; medicines for the treatment of anemia; medicines for the treatment of dwarfism; medicines for the treatment of inflammatory bowel disease; medicines for the treatment of short-bowel syndrome; medicines for the treatment of psoriasis; medicines for the treatment of proliferative arthritis; medicines for the treatment of systemic lupus erythematosus; medicines for the treatment of cervical tumor

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2015-05-07	1 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2015-05-12	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2015-05-12	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2015-05-12	4 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2015-05-13	5 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2015-05-13	6 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2015-05-13	7 RFCS P:
APPLICATION FILING RECEIPT MAILED	2015-05-16	8 MAFR O:Outgoing Correspondence
REFUSAL PROCESSED BY IB	2015-06-02	9 RFNT P:
CHANGE OF NAME/ADDRESS REC'D FROM IB	2015-06-26	10 ADCH M:
ASSIGNED TO EXAMINER	2015-12-14	11 DOCK D:Assigned to Examiner
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2015-12-15	12 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2015-12-15	13 MAB2 O:Outgoing Correspondence
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	2016-10-12	14 OPNR P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	2016-10-12	15 OPNS P:
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	2016-10-28	16 OPNX P:
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2016-12-15	17 FICR P:
FINAL DISPOSITION NOTICE SENT TO IB	2016-12-15	18 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2016-12-30	19 FINT P:
NEW REPRESENTATIVE AT IB RECEIVED	2020-05-28	20 NREP P:

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.